Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events (Details)

v3.19.2
Subsequent Events (Details)
1 Months Ended
Aug. 31, 2019
USD ($)
Clinical Trial Agreement [Member] | Subsequent Event [Member]  
Subsequent Event [Line Items]  
Estimated Research Costs $ 3,200,000